<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39463502</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and Good's Syndrome After Thymectomy.</ArticleTitle><Pagination><StartPage>e70274</StartPage><MedlinePgn>e70274</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70274</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.70274</ELocationID><Abstract><AbstractText>Good's syndrome is a rare secondary immunodeficiency characterised by recurrent infection and hypogammaglobulinemia associated with thymus tumour, and symptoms of recurrent infection may persist even after thymectomy. It is characterised by increased susceptibility to bacterial, viral, and fungal infections, as well as autoimmunity. Immunoglobulin replacement therapy has been reported to decrease infection rate, hospitalization, and the rate of antibiotic use in these patients. There are very few reported cases of patients with COVID-19 infection and Good's syndrome; however, there is no strong association proven between these two situations. The patient we report in this article had a COVID-19 infection first, was incidentally diagnosed with thymoma, and got the symptoms of Good's syndrome after thymectomy.</AbstractText><CopyrightInformation>Copyright © 2024, May et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>May</LastName><ForeName>Ingyin</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Medicine, King's College Hospital NHS Foundation Trust, London, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akunuri</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Medicine, King's College Hospital NHS Foundation Trust, London, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">good's syndrome</Keyword><Keyword MajorTopicYN="N">immunodeficiency</Keyword><Keyword MajorTopicYN="N">recurrent infection</Keyword><Keyword MajorTopicYN="N">thymectomy</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39463502</ArticleId><ArticleId IdType="pmc">PMC11512625</ArticleId><ArticleId IdType="doi">10.7759/cureus.70274</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Good's syndrome with clinical manifestation after thymectomy: a case report. Furukawa R, Yanagiya M, Matsumoto J, Hashimoto H, Horiuchi H, Usui K. https://www.sciencedirect.com/science/article/pii/S2213007117303222?via%3Dihub. Respir Med Case Rep. 2018;24:89–91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6010670</ArticleId><ArticleId IdType="pubmed">29977769</ArticleId></ArticleIdList></Reference><Reference><Citation>Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications. Malphettes M, Gérard L, Galicier L, et al. Clin Infect Dis. 2015;61:0–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25828999</ArticleId></ArticleIdList></Reference><Reference><Citation>Case report and literature review on Good's syndrome, a form of acquired immunodeficiency associated with thymomas. Joven MH, Palalay MP, Sonido CY. https://pubmed.ncbi.nlm.nih.gov/23467629/#. Hawaii J Med Public Health. 2013;72:56–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3585500</ArticleId><ArticleId IdType="pubmed">23467629</ArticleId></ArticleIdList></Reference><Reference><Citation>Good's syndrome and COVID-19: case report and literature review. Berzenji L, Yogeswaran SK, Snoeckx A, Van Schil PE, Wener R, Hendriks JM. Mediastinum. 2023;7:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10011861</ArticleId><ArticleId IdType="pubmed">36926289</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia) Zaman M, Huissoon A, Buckland M, et al.  https://pubmed.ncbi.nlm.nih.gov/30216434/ Clin Exp Immunol. 2019;195:132–138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6300645</ArticleId><ArticleId IdType="pubmed">30216434</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>